MedPath

Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach

Not yet recruiting
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
Other: Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
First Posted Date
2023-11-30
Last Posted Date
2023-11-30
Lead Sponsor
Fudan University
Target Recruit Count
51
Registration Number
NCT06151691
Locations
🇨🇳

Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China, Shanghai, China

mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer

Phase 2
Recruiting
Conditions
Pancreatic Adenocarcinoma
Interventions
Combination Product: mFOLFIRINOX plus radiotherapy
First Posted Date
2023-11-29
Last Posted Date
2024-06-06
Lead Sponsor
Fudan University
Target Recruit Count
30
Registration Number
NCT06149689
Locations
🇨🇳

Shanghai Cancer Center, Shanghai, China

Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction

Not Applicable
Completed
Conditions
Postoperative Pain
Mammary Cancer
Erector Spinae Plane Block
Interventions
Procedure: Erector spinae plane block
First Posted Date
2023-11-22
Last Posted Date
2024-03-06
Lead Sponsor
Fudan University
Target Recruit Count
100
Registration Number
NCT06143020
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

IASLC Grading System as a Predictor for EGFR-TKI Therapy

Completed
Conditions
Lung Cancer
First Posted Date
2023-11-14
Last Posted Date
2023-12-13
Lead Sponsor
Fudan University
Target Recruit Count
2160
Registration Number
NCT06131645
Locations
🇨🇳

Chaoqiang Deng, Shanghai, Please Select, China

Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

Phase 2
Recruiting
Conditions
Adenocarcinoma
Metastatic Gastric Cancer
Stomach Neoplasm
Oligometastatic Disease
Adenocarcinoma of the Stomach
Metastatic Cancer
Gastroesophageal Junction Adenocarcinoma
Metastatic Adenocarcinoma
Gastroesophageal-junction Cancer
Interventions
Radiation: Radiotherapy targeted to the primary lesion
Radiation: Radiotherapy targeted to the metastatic lesions
Biological: Anti-PD-1 monoclonal antibody
Biological: Trastuzumab
Drug: Chemotherapy
Procedure: R0 total/subtotal gastrectomy with D2 lymphadenectomy
Procedure: Metastasectomy
Procedure: Local ablative therapies
First Posted Date
2023-11-08
Last Posted Date
2023-11-08
Lead Sponsor
Fudan University
Target Recruit Count
55
Registration Number
NCT06121700
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence

Phase 2
Recruiting
Conditions
Liver Metastases
Radiotherapy
Immunotherapy
Colorectal Cancer
Interventions
Radiation: SBRT
Drug: Chemotherapy
Drug: PD-1 antibody
First Posted Date
2023-11-07
Last Posted Date
2023-11-07
Lead Sponsor
Fudan University
Target Recruit Count
80
Registration Number
NCT06120127
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma

Not Applicable
Not yet recruiting
Conditions
Soft Tissue Sarcoma Adult
Interventions
First Posted Date
2023-10-31
Last Posted Date
2023-10-31
Lead Sponsor
Fudan University
Target Recruit Count
29
Registration Number
NCT06110650

Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

Phase 3
Not yet recruiting
Conditions
Wedge Resection
Ground-glass Opacity
Lung Cancer
Interventions
Procedure: Wedge resection
First Posted Date
2023-10-26
Last Posted Date
2023-10-26
Lead Sponsor
Fudan University
Target Recruit Count
286
Registration Number
NCT06102161
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

A Retrospective Analysis of Incisional Hernia Repair's Postoperative Recurrence

Completed
Conditions
Incisional Hernia
Recurrent Hernia
Interventions
Behavioral: Recurrence after surgery
First Posted Date
2023-10-26
Last Posted Date
2023-10-26
Lead Sponsor
Fudan University
Target Recruit Count
157
Registration Number
NCT06102551
Locations
🇨🇳

YiMing Lin, Shanghai, Shanghai, China

Surveillance for Multifocal GGNs

Recruiting
Conditions
Lung Ground-glass Opacities
Active Surveillance
Interventions
Procedure: Watchful waiting
First Posted Date
2023-10-24
Last Posted Date
2025-01-31
Lead Sponsor
Fudan University
Target Recruit Count
370
Registration Number
NCT06097910
Locations
🇨🇳

Fudan University Cancer Center, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath